MarginsXMarginsX
Home › Markets › BCAB

BioAtla, Inc. (BCAB)

BCAB is quoted over the counter, not listed on an exchange. BioAtla, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$1.99
+27.6% on the day
1-year return
-95.0%
Market cap
$3.3M
Nano cap. From the Nov 16, 2026 close × 1.7M shares (10-Q cover page, Aug 10, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerBCAB, quoted over the counter
SEC CIK0001826892
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressSan Diego, CA
Incorporated inDE

Warning signs

Cash runway
0.8 months
$1.5M cash at June 30, 2026
Share count, 1 year
+41.9%
2025-07-31 to 2026-07-31
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Management's assessment concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the issuance date of these condensed consolidated financial statements."
10-Q 2026-08-13
Cash and burn$1.5M cash; operating cash flow -$5.9M a quarter.Report 2026-06-30
Shares outstanding1,666,100 (2026-07-31); 58,721,588 a year earlier. 1y figure adjusted for split (1-for-50 overall).Cover page 2026-07-31
Reverse splits, 3 years1; latest 1-for-50 on 2026-04-06Source 2026-04-06
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-11-21
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-08-28
AuditorErnst & Young LLP, San Diego, California, United StatesPCAOB Form AP 2026-10-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed$452K-$419K$1.5MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$6.3M-$5.3M$2.0MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
Not filed-$9.8M-$7.9M$7.1MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$15.8M-$9.9M$8.3MNo debt tagsNeeds four quarters10-Q 2025-11-13
Q2 2025
2025-06-30
Not filed-$18.7M-$14.1M$18.2MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$15.3M-$16.3M$32.4MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2024
2024-12-31
Not filed-$14.9M-$16.8M$49.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$10.6M-$5.1M$56.5MNo debt tagsNeeds four quarters10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-10-29
Latest annual report10-K/A2026-04-29
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-10-20
Latest proxyDEFA14A2026-06-03

Source: SEC EDGAR submissions feed, 510 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier